# DAKLINZA
> **NDA206843** · New Drug Application · Sponsor: BRISTOL-MYERS SQUIBB · Approved 2015-07-24
## Drug
- **FDA Application Number:** NDA206843
- **Application type:** New Drug Application
- **Brand name:** DAKLINZA
- **Generic name:** Daclatasvir Dihydrochloride
- **Active ingredients:** DACLATASVIR DIHYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** BRISTOL-MYERS SQUIBB
- **First approval:** 2015-07-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206843)
---
*MORVS · CC0 1.0*